Insider · CIK 0002014866
Ryan Preblick
Files at INDV (Indivior Pharmaceuticals, Inc.). First filing -, latest -.
Ryan Preblick files SEC Form 4 as CFO at INDV (Indivior Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ryan Preblick has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 14, 2026 | INDV Indivior Pharmaceuticals, Inc. | MOption exercise Common Stock | +6,302 | - | - | 323,594 | Mar 17, 2026 |
| Mar 14, 2026 | INDV Indivior Pharmaceuticals, Inc. | FTax withholding Common Stock | -2,843 | $31.11 | $88k | 320,751 | Mar 17, 2026 |
| Mar 14, 2026 | INDV Indivior Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -6,302 | - | - | 0 | Mar 17, 2026 |
| Mar 3, 2026 | INDV Indivior Pharmaceuticals, Inc. | FTax withholding Common Stock | -87,597 | $31.98 | $2.8M | 230,343 | Mar 5, 2026 |
| Mar 3, 2026 | INDV Indivior Pharmaceuticals, Inc. | MOption exercise Common Stock | +86,949 | - | - | 317,292 | Mar 5, 2026 |
| Mar 3, 2026 | INDV Indivior Pharmaceuticals, Inc. | MOption exercise Performance Stock Unitsderivative | -113,510 | - | - | 0 | Mar 5, 2026 |
| Feb 10, 2026 | INDV Indivior Pharmaceuticals, Inc. | AGrant or award Common Stock | +37,358 | $0.00 | $0 | 317,940 | Feb 12, 2026 |
| Feb 9, 2026 | INDV Indivior Pharmaceuticals, Inc. | AGrant or award Performance Stock Unitsderivative | +113,510 | $0.00 | $0 | 113,510 | Feb 12, 2026 |
Questions about Ryan Preblick
Answered from the filings on this page, as of the latest one.
Is Ryan Preblick buying or selling?
Ryan Preblick has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ryan Preblick's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ryan Preblick has 0.
Where does Ryan Preblick file Form 4?
Ryan Preblick has filed Form 4 at INDV (Indivior Pharmaceuticals, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.